Group items tagged

Something radically new. A pharmaceutical company integrating downstream to the point of setting up an e-payment system enabling it to sell direct to patients and to set up additional value-added services, such as checking prescription compliance.

An interesting article on the way with which pharmaceutical companies are now paying attention to the design of drug delivery devices. Economic value is probably easier to achieve in this neglected area than in looking for the next blockbuster drug?

A brief editorial comment on the problem of conflicts of interest that emerge between companies that sponsor academic research and the recipients of such grants. Of course, when the field is pharmaceuticals, the problems become very big.

Innovation sometimes creates new and "hybrid" industries. In this case it is "nutraceuticals", a blend between food and pharma. Drivers are customer demand for a more healthy life, food companies looking for higher added-value products, and pharma companies finding it ever more difficult to find new drugs rewarding the huge R&D effort required